Cardinal Health (CAH) Earnings: Results, Guidance and Stock Reaction
Cardinal Health's latest report was Q1 FY2027 on November 5, 2026 (before the open): Beat and raise, and the stock moved +4.8% on it. Below: the numbers vs Wall Street, then every quarter we've explained in plain English.
Latest: Q1 FY2027 vs consensus
| Metric | Reported | Consensus | Result |
|---|---|---|---|
| Non-GAAP EPS | $3.26 (+28%) | $2.94 (Benzinga Pro) | Beat |
| Revenue | $67.5B (+5%) | $66.51B (Benzinga Pro) | Beat |
| GAAP EPS | $2.38 (+27%) | n/a | |
| FY2027 non-GAAP EPS guidance | $12.80 to $13.00 (was $12.40 to $12.60) | n/a | Raised |
Full CAH Q1 FY2027 explainer: what mattered, the reaction and Max's verdict →
Every Cardinal Health report we've explained
- Q1 FY2027 (November 5, 2026, before the open): Beat and raise · stock +4.8% after
Get the next CAH report explained in your inbox.
Every big earnings report in plain English: beat or miss, guidance, and how the stock took it. No spam, unsubscribe anytime.
FAQ
Did Cardinal Health (CAH) beat earnings last quarter?
In Q1 FY2027, reported November 5, 2026, Cardinal Health came in Beat and raise. Non-GAAP EPS: $3.26 (+28%) vs $2.94 (Benzinga Pro); Revenue: $67.5B (+5%) vs $66.51B (Benzinga Pro).
When did Cardinal Health last report earnings?
Cardinal Health reported Q1 FY2027 results on November 5, 2026, before the open.
Earnings, explained in plain English. Free at 7 AM.
Every morning: who beat, who missed, what the guidance means and how the stock took it, plus 3-month stock calls graded vs the S&P 500.